文献速递乳房整形与再造瘢痕与激光

睾酮替代治疗对性别肯定乳房切除术瘢痕质量的影响

Effect of testosterone replacement therapy on scar quality in gender-affirming mastectomies.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2024-02-01

这项回顾性观察性队列研究纳入170例2003年至2021年间由资深作者实施性别肯定乳房切除术的患者,其中睾酮组与非睾酮组各63例,由盲法评估者用Stony Brook瘢痕评估量表(SBSES)评分。两组SBSES平均分分别为2.74与2.66,差异无统计学意义。作者结论为未发现睾酮治疗对术后手术瘢痕有显著影响。

要点

  • 睾酮组SBSES平均分2.74,非睾酮组2.66,差异无统计学意义。
  • 研究为回顾性观察性队列,证据等级为3级。
  • 作者未发现睾酮治疗对术后瘢痕有显著影响。

核心结论

  • 作者在本回顾性队列研究中未发现睾酮治疗对术后手术瘢痕有显著影响。

研究设计与样本

  • 回顾性观察性队列研究,收集2003年至2021年间由资深作者实施性别肯定乳房切除术的170例患者资料。
  • 分析病历获取个人、医疗(包括睾酮治疗时长)与手术信息,由盲法评估者审阅术后临床照片。
  • 采用经验证的Stony Brook瘢痕评估量表(SBSES)对瘢痕评分,证据等级为3级。

主要发现

  • 睾酮组63例与非睾酮组63例的SBSES平均分分别为2.74与2.66,两组差异无统计学意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The term transgenders refer to people who sense discordance between their gender identity and the sex assigned to them at birth. Some transgenders receive hormonal therapy, which may lead to specific skin conditions. The purpose of the present study was to determine whether a causal relationship exists between hormonal therapy (specifically testosterone therapy) and unsatisfying surgical scarring, including hypertrophic and keloid scars. In addition, this study may serve as a basis for future studies, which may test means that aim to reduce such undesired effects. METHODS: In this retrospective, observational cohort study, data were collected regarding 170 patients who underwent mastectomy as a gender-affirming surgery by the senior author between 2003 and 2021. The medical records were analysed to obtain personal, medical (including the duration of testosterone treatment) and surgical information from the patients' medical files. A blinded evaluator assessed the surgical scars by reviewing the postoperative clinical pictures of the patients. The scars were rated using the validated Stony Brook Scar Evaluation Scale (SBSES). The use of pictures to assess surgical scars is described in the validation study of the SBSES and is, therefore, accepted. RESULTS: In total, 63 patients were included in the testosterone group and 63 were included in the non-testosterone treated group. The averages of the SBSES score were 2.74 and 2.66, respectively. The difference between the two averages was not statistically significant. CONCLUSION: In our retrospective cohort study, we did not find the effect of testosterone therapy on post-operative surgical scars to be significant. EVIDENCE BASED MEDICINE (EBM) LEVEL: 3.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Wolf Y, Skorochod R, Elias S, et al. Effect of testosterone replacement therapy on scar quality in gender-affirming mastectomies. J Plast Reconstr Aesthet Surg. 2024. PMID: 38447505. doi:10.1016/j.bjps.2024.01.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。